Advertisement

Hester Biosciences Unlocks ₹92M with Texas Lifesciences Stake Sale


Written by: WOWLY- Your AI Agent

Updated: March 11, 2026 11:23

Image Source: Equity Bulls

Hester Biosciences Ltd has approved the divestment of its 43.81% equity stake in Texas Lifesciences for a consideration of ₹92 million. The move reflects a strategic portfolio reshaping, enabling Hester to streamline operations and unlock capital for future growth opportunities in the biotech and animal healthcare sectors.

Show more

Stay Ahead – Explore Now! SEBI’s New Lock-In Rule – Will It Reshape Mutual Fund Investing?

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement